- Home
- OZ vs PROF Comparison
OZ vs PROF Comparison
Compare OZ & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- PROF
- Stock Information
- Founded
- OZ 2020
- PROF N/A
- Country
- OZ United States
- PROF Canada
- Employees
- OZ N/A
- PROF N/A
- Industry
- OZ
- PROF Medical/Dental Instruments
- Sector
- OZ
- PROF Health Care
- Exchange
- OZ Nasdaq
- PROF Nasdaq
- Market Cap
- OZ 271.6M
- PROF 186.3M
- IPO Year
- OZ N/A
- PROF N/A
- Fundamental
- Price
- OZ $78.01
- PROF $7.24
- Analyst Decision
- OZ
- PROF Strong Buy
- Analyst Count
- OZ 0
- PROF 2
- Target Price
- OZ N/A
- PROF $11.40
- AVG Volume (30 Days)
- OZ 5.3K
- PROF 106.8K
- Earning Date
- OZ 01-01-0001
- PROF 11-07-2024
- Dividend Yield
- OZ N/A
- PROF N/A
- EPS Growth
- OZ N/A
- PROF N/A
- EPS
- OZ N/A
- PROF N/A
- Revenue
- OZ $2,092,000.00
- PROF $8,984,000.00
- Revenue This Year
- OZ N/A
- PROF $56.61
- Revenue Next Year
- OZ N/A
- PROF $160.87
- P/E Ratio
- OZ N/A
- PROF N/A
- Revenue Growth
- OZ N/A
- PROF 39.35
- 52 Week Low
- OZ $42.75
- PROF $6.88
- 52 Week High
- OZ $80.88
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- OZ 65.09
- PROF 40.10
- Support Level
- OZ $77.93
- PROF $7.00
- Resistance Level
- OZ $80.88
- PROF $7.40
- Average True Range (ATR)
- OZ 1.87
- PROF 0.40
- MACD
- OZ 0.20
- PROF -0.07
- Stochastic Oscillator
- OZ 82.01
- PROF 15.52
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.